Funding Rounds
NRG Therapeutics

NRG Therapeutics Series A (2022, $18M)

NRG Therapeutics

Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $18.05M

Raised Date: 2022-01-01